Towards sound based testing of COVID-19 -- Summary of the first Diagnostics of COVID-19 using Acoustics Challenge

The technology development for point-of-care tests (POCTs) targeting respiratory diseases has witnessed a growing demand in the recent past. Investigating the presence of acoustic biomarkers in modalities such as cough, breathing and speech sounds, and using them for building POCTs can offer fast, contactless and inexpensive testing. In view of this, over the past year, we launched the ``Coswara'' project to collect cough, breathing and speech sound recordings via worldwide crowdsourcing. With this data, a call for development of diagnostic tools was announced in the Interspeech 2021 as a special session titled ``Diagnostics of COVID-19 using Acoustics (DiCOVA) Challenge''. The goal was to bring together researchers and practitioners interested in developing acoustics-based COVID-19 POCTs by enabling them to work on the same set of development and test datasets. As part of the challenge, datasets with breathing, cough, and speech sound samples from COVID-19 and non-COVID-19 individuals were released to the participants. The challenge consisted of two tracks. The Track-1 focused only on cough sounds, and participants competed in a leaderboard setting. In Track-2, breathing and speech samples were provided for the participants, without a competitive leaderboard. The challenge attracted 85 plus registrations with 29 final submissions for Track-1. This paper describes the challenge (datasets, tasks, baseline system), and presents a focused summary of the various systems submitted by the participating teams. An analysis of the results from the top four teams showed that a fusion of the scores from these teams yields an area-under-the-curve of 95.1% on the blind test data. By summarizing the lessons learned, we foresee the challenge overview in this paper to help accelerate technology for acoustic-based POCTs.

Multi-modal Point-of-Care Diagnostics for COVID-19 Based On Acoustics and Symptoms

The research direction of identifying acoustic bio-markers of respiratory diseases has received renewed interest following the onset of COVID-19 pandemic. In this paper, we design an approach to COVID-19 diagnostic using crowd-sourced multi-modal data. The data resource, consisting of acoustic signals like cough, breathing, and speech signals, along with the data of symptoms, are recorded using a web-application over a period of ten months. We investigate the use of statistical descriptors of simple time-frequency features for acoustic signals and binary features for the presence of symptoms. Unlike previous works, we primarily focus on the application of simple linear classifiers like logistic regression and support vector machines for acoustic data while decision tree models are employed on the symptoms data. We show that a multi-modal integration of acoustics and symptoms classifiers achieves an area-under-curve (AUC) of 92.40, a significant improvement over any individual modality. Several ablation experiments are also provided which highlight the acoustic and symptom dimensions that are important for the task of COVID-19 diagnostics.

DiCOVA Challenge: Dataset, task, and baseline system for COVID-19 diagnosis using acoustics

The DiCOVA challenge aims at accelerating research in diagnosing COVID-19 using acoustics (DiCOVA), a topic at the intersection of speech and audio processing, respiratory health diagnosis, and machine learning. This challenge is an open call for researchers to analyze a dataset of sound recordings collected from COVID-19 infected and non-COVID-19 individuals for a two-class classification. These recordings were collected via crowdsourcing from multiple countries, through a website application. The challenge features two tracks, one focusing on cough sounds, and the other on using a collection of breath, sustained vowel phonation, and number counting speech recordings. In this paper, we introduce the challenge and provide a detailed description of the task, and present a baseline system for the task.